Home Cart Sign in  
Chemical Structure| 315224-26-1 Chemical Structure| 315224-26-1

Structure of AMG131
CAS No.: 315224-26-1

Chemical Structure| 315224-26-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AMG-131 is a hypoglycemic agent. It is a potent PPARγ partial agonist that displays robust glucose-lowering activity in rodent models of diabetes while exhibiting a reduced side-effects profile compared to marketed TZDs.

Synonyms: INT131

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AMG131

CAS No. :315224-26-1
Formula : C21H12Cl4N2O3S
M.W : 514.21
SMILES Code : O=S(C1=CC=C(Cl)C=C1Cl)(NC2=CC(Cl)=C(OC3=CC4=CC=CC=C4N=C3)C(Cl)=C2)=O
Synonyms :
INT131
MDL No. :MFCD13152369
InChI Key :NMRWDFUZLLQSBN-UHFFFAOYSA-N
Pubchem ID :10229498

Safety of AMG131

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00952445 Diabetes Mellitus, Type II Phase 2 Completed - United States, California ... More >> Whittier Diabetes Institute La Jolla, California, United States Charles R. Drew University Los Angeles, California, United States National Research Institute Los Angeles, California, United States Lovelace Research Institute Santa Ana, California, United States United States, Florida University of Miami Miami, Florida, United States United States, Indiana GFI Research Center Evansville, Indiana, United States United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States United States, Minnesota Radiant Research Edina, Minnesota, United States United States, Missouri Radiant Research St. Louis, Missouri, United States St Louis Center for Clinical Research St. Louis, Missouri, United States United States, New York Kaleida Health Diabetes Center Buffalo, New York, United States Rochester Clinical Research Rochester, New York, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States United States, Oregon Radiant Research Portland, Oregon, United States United States, South Carolina Radiant Research Anderson, South Carolina, United States United States, Texas Baylor University Endocrine Center Dallas, Texas, United States Dallas Diabetes and Endocrine Research Center Dallas, Texas, United States Endocrine Associates of Dallas Dallas, Texas, United States Diabetes and Grandular Disease Clinic and Reseach Center San Antonio, Texas, United States United States, Utah Endocrine Research Specialists Ogden, Utah, United States United States, Virginia Salem VA Medical Center Salem, Virginia, United States Less <<
NCT02638038 Multiple Sclerosis, Relapsing ... More >>Remitting Less << PHASE2 COMPLETED 2016-12-12 -
NCT00631007 - Completed - -
NCT00631007 Type 2 Diabetes Mellitus Phase 2 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.72mL

1.94mL

0.97mL

19.45mL

3.89mL

1.94mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories